Cargando…
Extracellular Vesicles as Therapeutic Agents in Systemic Lupus Erythematosus
Systemic lupus erythematosus (SLE) is a heterogeneous autoimmune disease that affects multiple organs. Currently, therapeutic molecules present adverse side effects and are only effective in some SLE patient subgroups. Extracellular vesicles (EV), including exosomes, microvesicles and apoptotic bodi...
Autores principales: | Perez-Hernandez, Javier, Redon, Josep, Cortes, Raquel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412303/ https://www.ncbi.nlm.nih.gov/pubmed/28350323 http://dx.doi.org/10.3390/ijms18040717 |
Ejemplares similares
-
Extracellular Vesicles as Biomarkers of Systemic Lupus Erythematosus
por: Perez-Hernandez, Javier, et al.
Publicado: (2015) -
Increased Urinary Exosomal MicroRNAs in Patients with Systemic Lupus Erythematosus
por: Perez-Hernandez, Javier, et al.
Publicado: (2015) -
The Role of Extracellular Vesicles in Systemic Lupus Erythematosus
por: Zheng, Chenghui, et al.
Publicado: (2022) -
Novel therapeutic agents in clinical development for systemic lupus erythematosus
por: Jordan, Natasha, et al.
Publicado: (2013) -
Extracellular Vesicles in Rheumatoid Arthritis and Systemic Lupus Erythematosus: Functions and Applications
por: Zhang, Bo, et al.
Publicado: (2021)